UPDATE 3-Lilly's weight-loss pill improves sleep apnea in late-stage trial

* Lilly plans to seek US approval for Foundayo in sleep apnea by year-end * Foundayo users lose about 28 pounds on average during study, Lilly says * Shares rose more than 3% after the trial results (

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)